BIO Unveils Preliminary Program for the 2012 BIO Convention in China

Event to take place in Shanghai, China, October 24-25, 2012

BIO Unveils Preliminary Program for the 2012 BIO Convention in China

Biotechnology Industry OrganizationAbigail Hirsch, 202-962-9235

The Biotechnology Industry Organization (BIO) announces the 2 annual , a partnering and investor conference that will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities with China's emerging biotech sector. The event will take place October 24-25, 2012 in Shanghai, China.

“As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO. "Through distinguished speakers, exemplary programming, compelling company presentations and exhibiting and networking opportunities, BIO China allows attendees to explore the vast business opportunities afforded by China’s emerging biotech sector.”

Dr. Michael Rosenblatt, M.D., executive vice president and chief medical officer for Merck, will provide one of two keynote addresses on October 25th. Directly following Dr. Rosenblatt’s keynote, Peng Wang, Ph.D., Chief Scientific Officer, Simcere will deliver his remarks. Governor Jon Huntsman, former U.S. Ambassador to China and Governor of Utah, will provide the third keynote address. Additional keynote speakers will be announced at a later date.

Panel sessions will highlight the latest issues and trends related to doing business in China. Preliminary program topics include the globalization of Chinese companies; innovation in generics and biosimilars; comparative legal systems in – U.S., Europe and China; R&D trends in China; trends in cancer research and regulatory review in China.

BIO and the BIO China Advisory Committee set the event agenda and program. Advisory Committee members include:

BIO brings to China more than 15 years of experience in organizing international conferences for the biotech industry, including the BIO International Convention – the global event for biotechnology. BIO is renowned for its successful business development, partnering and investor meetings in North America, Europe and Asia. Partnering at this conference will be powered by BIO One-on-One Partnering an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors.

For more information on the BIO Convention in China, please visit .

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces , an online portal and monthly newsletter chronicling “innovations transforming our world.” .

September 12-13, 2012Mumbai, India

September 19-21, 2012Kansas City, MO

October 9-10, 2012San Francisco, CA

October 10-12, 2012Vancouver, Canada

October 24-25, 2012Shanghai, China

November 12-14, 2012Charleston, SC